Skip to main content
Drug Name DARZALEX® (daratumumab)
Drug Class
Immunosuppressant
Risk minimization type
Direct Healthcare Professional Communication DHPC
Specialty (Theraputic area)
Oncology
Risk

Incorrect information about solution concentration in Arabic section of the outer pack.

Dear Healthcare provider letter DHPC